When.com Web Search

  1. Ads

    related to: robitussin ac where to buy cheap products

Search results

  1. Results From The WOW.Com Content Network
  2. Robitussin cough syrup recall issued nationwide due to ... - AOL

    www.aol.com/robitussin-cough-syrup-recall-issued...

    Robitussin Honey CF Max Day and Nighttime are cough syrups indicted for the temporary relief of symptoms occurring with cold or flu, hay fever, or other respiratory allergies, according to Haleon.

  3. 8 Lots of This Popular Cough Syrup Have Been Recalled ... - AOL

    www.aol.com/8-lots-popular-cough-syrup-202500662...

    If you have products from any of the affected lots, stop using them immediately and contact the Haleon Consumer Relations Team at 1-800-245-1040 (Monday through Friday, 8 a.m. to 6 p.m. ET) or ...

  4. Robitussin cough syrups are being recalled due to risk of ...

    www.aol.com/news/robitussin-cough-syrups-being...

    Robitussin cough syrup is being recalled due to microbial contamination that can lead to fungemia. Honey flavors are included in the 2024 recall.

  5. Dextromethorphan regulation by U.S. jurisdiction - Wikipedia

    en.wikipedia.org/wiki/Dextromethorphan...

    A person is prohibited to purchase more than 3.6 grams of dextromethorphan containing products within a 30-day period unless it is in pursuant to a valid prescription. Any person found in violation of this bill is guilty of a misdemeanor and subject to a fine of $1000, or imprisonment of not more than one year, or both the fine and the ...

  6. Guaifenesin/codeine - Wikipedia

    en.wikipedia.org/wiki/Guaifenesin/codeine

    Guaifenesin/codeine is a fixed-dose combination cold medicine used for the treatment of cough. [1] It contains guaifenesin, an expectorant; and codeine, as the phosphate, an opioid antitussive. [1]

  7. Dextromethorphan - Wikipedia

    en.wikipedia.org/wiki/Dextromethorphan

    Dextromethorphan, sold under the brand name Robitussin among others, is a cough suppressant used in many cough and cold medicines. [6] In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder .